Abstract
Over the past decade there have been significant advances in the treatment of acute myelogenous leukemia (AML). The introduction of intensive induction and post-remission chemotherapy programs, together with the improvement in supportive care, have resulted in a probability of long-term survival in 30%–50% of children with AML [1–4]. In 1982 the AIEOP (Italian Pediatric Hematology-Oncology Association) cooperative group began a multicenter prospective trial for pediatric AML in order to establish the value of a polychemotherapeutic regimen consisting of intensive induction followed by intensive consolidation and continuation chemotherapy.
Supported by Consiglio Nazionale Ricerche (CNR), Progetto Finalizzato Oncologia (PFO) contract no. 87.02801.44 and by Ministero Pubblica Istruzione (MPI) 40%.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Creutzig U, Ritter J, Riehm H et al. (1985) Improved treatment results in childhood acute myelogenous leukemia: a report of the German Cooperative Study AML-BFM-78. Blood 65: 298–304
Weinstein HJ, Mayer RJ, Rosenthal DS et al. (1983) Chemotherapy for acute leukemia in children and adults: VAPA update. Blood 62: 315–319
Gale RP, Foon KA (1987) Therapy of acute myelogenous leukemia. Semin Hematol 24: 40–54
Kalwinsky D, Mirro J, Schell M et al. (1988) Early intensification of chemotherapy for childhood acute non-lymphoblastic leukemia: improved remission induction with a five drug regimen including Etoposide. J Clin Oncol 6: 1134–1143
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Amadori, S. et al. (1990). Therapy of Childhood Acute Myelogenous Leukemia: An Update of the AIEOP/LAM 8204 Study. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_40
Download citation
DOI: https://doi.org/10.1007/978-3-642-74643-7_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50984-4
Online ISBN: 978-3-642-74643-7
eBook Packages: Springer Book Archive